WallStreetZenWallStreetZen

NYSE: ALB
Albemarle Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ALB

Based on 18 analysts offering 12 month price targets for Albemarle Corp

Min Forecast
$140.00+32.35%
Avg Forecast
$191.61+81.14%
Max Forecast
$250.00+136.34%

Should I buy or sell ALB stock?

Based on 18 analysts offering ratings for Albemarle Corp.

Buy
Strong Buy
8 analysts 44.44%
Buy
3 analysts 16.67%
Hold
7 analysts 38.89%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ALB's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ALB as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their ALB stock forecasts and price targets.

ALB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-25
lockedlocked$00.00+00.00%2026-08-10
lockedlocked$00.00+00.00%2026-08-10
lockedlocked$00.00+00.00%2026-08-10
lockedlocked$00.00+00.00%2026-08-07
Citigroup
Bottom 6%
6
Strong BuyMaintains$175.00+65.44%2026-08-07
Truist Securities
Top 25%
76
Strong BuyMaintains$225.00+112.71%2026-08-07
Bank of America
Top 43%
58
Strong BuyReiterates$155.00+46.53%2026-08-07
Evercore ISI Group
Bottom 19%
19
HoldMaintains$180.00+70.16%2026-08-07
BMO Capital
Bottom 10%
10
BuyMaintains$200.00+89.07%2026-08-07

1 of 2

Forecast return on equity

Is ALB forecast to generate an efficient return?

Company
20.76%
Industry
37.17%
Market
168.54%
ALB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALB forecast to generate an efficient return on assets?

Company
13.41%
Industry
11.54%
ALB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALB earnings per share forecast

What is ALB's earnings per share in the next 3 years based on estimates from 23 analysts?

Avg 1 year Forecast
$11.65+2,378.7%
Avg 2 year Forecast
$11.07+2,255.09%
Avg 3 year Forecast
$11.88+2,427.43%
ALB's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ALB revenue forecast

What is ALB's revenue in the next 3 years based on estimates from 23 analysts?

Avg 1 year Forecast
$6.2B+4.42%
Avg 2 year Forecast
$6.3B+7.01%
Avg 3 year Forecast
$6.7B+12.59%
ALB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALB earnings growth forecast

How is ALB forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
190.96%
Industry
20.54%
Market
32.46%
ALB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ALB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ALB's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ALB revenue growth forecast

How is ALB forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
3.84%
Industry
5.06%
Market
14.47%
ALB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALB vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
ALB$105.78$191.61+81.14%Buy
RPM$98.67$129.14+30.88%Strong Buy
AVTR$15.05$12.39-17.68%Hold
SSL$13.82N/AN/ABuy
SOLS$56.32$80.50+42.93%Strong Buy
View Top Specialty Chemical Stocks

Albemarle Stock Forecast FAQ

Is Albemarle Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 18 Wall Street analysts covering (NYSE: ALB) stock is to Buy ALB stock.

Out of 18 analysts, 8 (44.44%) are recommending ALB as a Strong Buy, 3 (16.67%) are recommending ALB as a Buy, 7 (38.89%) are recommending ALB as a Hold, 0 (0%) are recommending ALB as a Sell, and 0 (0%) are recommending ALB as a Strong Sell.

If you're new to stock investing, here's how to buy Albemarle stock.

What is ALB's earnings growth forecast for 2026-2028?

(NYSE: ALB) Albemarle's forecast annual earnings growth rate of 190.96% is forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 20.54%, and it is also forecast to beat the US market's average forecast earnings growth rate of 32.46%.

Albemarle's earnings in 2026 is $57,427,000.On average, 23 Wall Street analysts forecast ALB's earnings for 2026 to be $1,374,747,114, with the lowest ALB earnings forecast at $1,187,673,697, and the highest ALB earnings forecast at $1,638,276,007. On average, 22 Wall Street analysts forecast ALB's earnings for 2027 to be $1,306,186,175, with the lowest ALB earnings forecast at $713,529,378, and the highest ALB earnings forecast at $1,975,546,260.

In 2028, ALB is forecast to generate $1,401,770,272 in earnings, with the lowest earnings forecast at $632,577,909 and the highest earnings forecast at $2,567,318,020.

What is ALB's revenue growth forecast for 2026-2028?

(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 3.84% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.47%.

Albemarle's revenue in 2026 is $5,907,904,000.On average, 23 Wall Street analysts forecast ALB's revenue for 2026 to be $727,973,196,633, with the lowest ALB revenue forecast at $670,386,728,817, and the highest ALB revenue forecast at $792,403,957,755. On average, 22 Wall Street analysts forecast ALB's revenue for 2027 to be $746,027,970,354, with the lowest ALB revenue forecast at $597,695,613,705, and the highest ALB revenue forecast at $898,608,509,055.

In 2028, ALB is forecast to generate $784,969,639,164 in revenue, with the lowest revenue forecast at $581,764,931,010 and the highest revenue forecast at $985,224,220,893.

What is ALB's forecast return on assets (ROA) for 2026-2029?

(NYSE: ALB) forecast ROA is 13.41%, which is higher than the forecast US Specialty Chemicals industry average of 11.54%.

What is ALB's Price Target?

According to 18 Wall Street analysts that have issued a 1 year ALB price target, the average ALB price target is $191.61, with the highest ALB stock price forecast at $250.00 and the lowest ALB stock price forecast at $140.00.

On average, Wall Street analysts predict that Albemarle's share price could reach $191.61 by Aug 25, 2027. The average Albemarle stock price prediction forecasts a potential upside of 81.14% from the current ALB share price of $105.78.

What is ALB's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: ALB) Albemarle's current Earnings Per Share (EPS) is $0.47. On average, analysts forecast that ALB's EPS will be $11.65 for 2026, with the lowest EPS forecast at $10.06, and the highest EPS forecast at $13.88. On average, analysts forecast that ALB's EPS will be $11.07 for 2027, with the lowest EPS forecast at $6.05, and the highest EPS forecast at $16.74. In 2028, ALB's EPS is forecast to hit $11.88 (min: $5.36, max: $21.76).

What is ALB's forecast return on equity (ROE) for 2026-2029?

(NYSE: ALB) forecast ROE is 20.76%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.